depression – Discover Pharma

Welcome to Discover Pharma! Today is : March 16, 2026

depression

Artificial Intelligence,Drug Development,Patient Centricity,Technology and platforms
Prenuvo research links alcohol and exercise to early brain and organ changes in asymptomatic adults
Two new studies presented at the 2025 ISMRM Annual Meeting [...]

June 27, 2025
Artificial Intelligence,Clinical Trials,Patient Centricity,Precision medicine,Regulatory Affairs,Technology and platforms
Rejoyn becomes first prescription-only app for depression in Great Britain with its mode of action
Clinically validated digital therapeutic launches with UKCA mark and NHS [...]

June 30, 2025
Drug Development,Precision medicine
Elkedonia raises EUR 11.25 million to develop new treatment for depression and other neuropsychiatric disorders
New approach targets Elk1 to restore neuroplasticity without sedation or [...]

June 12, 2025

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK